DAWNRAYS PHARMA (02348.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Aug23

East China Pharmaceutical Posts 78.79% Drop in Interim Profit

15:31

Aug22

DAWNRAYS PHARMA released FY2025 Q1 earnings on August 22 (BJT), actual revenue HKD 337.58 M, actual EPS HKD 0.0372

15:00

DAWNRAYS PHARMA released FY2025 Semi-Annual Earnings on August 22 During-Market (BJT), with actual revenue of HKD 682.59 M and EPS of HKD 0.0753

08:00

DAWNRAYS PHARMA released FY2025 Q2 earnings on August 22 During-Market BJT, actual revenue HKD 345.01 M, actual EPS HKD 0.038

08:00

Aug14

DAWNRAYS PHARMA to Release FY2025 Semi-Annual Earnings on August 22, 2025 (BJT)

00:45

Jul7

Precision Engineering International Increases Stake in Dongrui Pharmaceutical

12:50

Schedules & Filings

Schedules

Filings

Oct3

Distribution Plan(CST)

Cash dividend 0.015 HKD

Sep17

Distribution Plan(CST)

Cash dividend 0.015 HKD

Sep16

Distribution Plan(CST)

Cash dividend 0.015 HKD

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change